How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

7,345 results for

Diarrhea Secondary to Medications

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics

Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics 1 © American College of Medical Genetics and Genomics ACMG St And ArdS And GuidelineS PURPOSE This guideline is intended as an educational resource. It high- lights current practices and therapeutic approaches to the diagnosis and management of GSD I and its early and long- term complications. GENERAL BACKGROUND History In 1929, von Gierke described glycogen (...) storage disease type I (GSD I) after reviewing the autopsy reports of two children whose livers and kidneys contained excessive amounts of Submitted 12 August 2014; accepted 12 August 2014; advance online publication 6 November 2014. doi:10.1038/gim.2014.128 Genet Med 00 00 2014 Genetics in Medicine 10.1038/gim.2014.128 ACMG Standards and Guidelines 00 00 12August2014 12August2014 © American College of Medical Genetics and Genomics 6November2014 Purpose: Glycogen storage disease type I (GSD I

2014 American College of Medical Genetics and Genomics

82. Medical Management of Kidney Stones

. Hypocitraturia is a common risk factor for stone disease with an estimated prevalence of 20-60%. 81, 82 Urinary citrate excretion is determined by acid-base status; metabolic acidosis or dietary acid loads enhance renal citrate reabsorption, thereby reducing urinary excretion. A number of medical conditions such as renal tubular acidosis and chronic diarrhea, and some medications, such as carbonic anhydrase inhibitors, may promote hypocitraturia. 82 Acidosis can arise from a diet that is inordinately rich (...) Medical Management of Kidney Stones Kidney Stones: Medical Mangement Guideline - American Urological Association advertisement Toggle navigation About Us About the AUA Membership AUA Governance Industry Relations Education AUAUniversity Education Products & Resources Normal Histology and Important Histo-anatomic Structures Urinary Bladder Prostate Kidney Renovascular Diseases Andrenal Gland Testis Paratesticular Tumors Penis Retroperitoneum Cytology Online Learning For Medical Students Exams

2014 American Urological Association

83. Diarrhea (Diagnosis)

and parasites Leukocyte count pH level: A pH level of 5.5 or less or the presence of reducing substances indicates carbohydrate intolerance, which is usually secondary to viral illness Examination of exudates for presence/absence of leukocytes Cultures: Always culture for Salmonella, Shigella, and Campylobacter spp and Y enterocolitica in the presence of clinical signs of colitis or if fecal leukocytes are present; look for Clostridium difficile in those with diarrhea characterized by colitis and/or bloody (...) self-limited; however, an acute infection can have a protracted course. Management is generally supportive: In most cases, the best option for treatment of acute-onset diarrhea is the early use of oral rehydration therapy (ORT). [ ] Pharmacotherapy Vaccines (eg, rotavirus) can help increase resistance to infection. Antimicrobial and antiparasitic agents may be used to treat diarrhea caused by specific organisms and/or clinical circumstances. Such medications include the following: Cefixime

2014 eMedicine Pediatrics

84. Diarrhea (Treatment)

Diarrhea (Treatment) Diarrhea Treatment & Management: Medical Care, Consultations, Diet Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvOTI4NTk4LXRyZWF0bWVudA== processing > Diarrhea Treatment & Management Updated (...) : Oct 31, 2018 Author: Stefano Guandalini, MD; Chief Editor: Carmen Cuffari, MD Share Email Print Feedback Close Sections Sections Diarrhea Treatment Medical Care In 2003 the Center for Disease Control (CDC) put forth recommendations for the management of acute pediatric diarrhea in both the outpatient and inpatient settings including indication for referral. [ ] Indications for medical evaluation of children with acute diarrhea include the following: Younger than 3 months Weight of less than 8 kg

2014 eMedicine Pediatrics

85. Diarrhea (Overview)

and parasites Leukocyte count pH level: A pH level of 5.5 or less or the presence of reducing substances indicates carbohydrate intolerance, which is usually secondary to viral illness Examination of exudates for presence/absence of leukocytes Cultures: Always culture for Salmonella, Shigella, and Campylobacter spp and Y enterocolitica in the presence of clinical signs of colitis or if fecal leukocytes are present; look for Clostridium difficile in those with diarrhea characterized by colitis and/or bloody (...) self-limited; however, an acute infection can have a protracted course. Management is generally supportive: In most cases, the best option for treatment of acute-onset diarrhea is the early use of oral rehydration therapy (ORT). [ ] Pharmacotherapy Vaccines (eg, rotavirus) can help increase resistance to infection. Antimicrobial and antiparasitic agents may be used to treat diarrhea caused by specific organisms and/or clinical circumstances. Such medications include the following: Cefixime

2014 eMedicine Pediatrics

86. Diarrhea (Follow-up)

J, Horner B, Mutters R, Rodloff AC. Epidemiology and Recurrence Rates of Clostridium difficile Infections in Germany: A Secondary Data Analysis. Infect Dis Ther . 2016 Oct 21. . Esposito DH, Holman RC, Haberling DL, Tate JE, Podewils LJ, Glass RI, et al. Baseline estimates of diarrhea-associated mortality among United States children before rotavirus vaccine introduction. Pediatr Infect Dis J . 2011 Nov. 30(11):942-7. . Mehal JM, Esposito DH, Holman RC, Tate JE, Sinden LL, Parashar UD. Risk (...) summary. J Pediatr Gastroenterol Nutr . 2008 May. 46(5):619-21. . [Guideline] Atia AN, Buchman AL. Oral rehydration solutions in non-cholera diarrhea: a review. Am J Gastroenterol . 2009 Oct. 104(10):2596-604; quiz 2605. . Kling J. Green Tea and Pomegranate Extract Help Fight Diarrhea in Children. Medscape Medical News. Available at . Accessed: October 24, 2014. Guandalini S. Probiotics for prevention and treatment of diarrhea. J Clin Gastroenterol . 2011 Nov. 45 Suppl:S149-53. . Ruiz-Palacios GM

2014 eMedicine Pediatrics

87. Long-Term Medical Management of the Pediatric Patient After Liver Transplantation

Long-Term Medical Management of the Pediatric Patient After Liver Transplantation SPECIAL ARTICLE Long-Term Medical Management of the Pediatric Patient After Liver Transplantation: 2013 Practice Guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation Deirdre A. Kelly, 1 John C. Bucuvalas, 2 Estella M. Alonso, 3 Saul J. Karpen, 4 Upton Allen, 5 Michael Green, 6 Douglas Farmer, 7 Eyal Shemesh, 8 and Ruth A. McDonald 9 1 Liver Unit (...) and the American Gastroenterological Association policy statement on the use of medical practice guidelines 2 ; and (4) the experience of the authors in managing children under- going liver transplantation (LT). Intended for use by pediatricians and physicians, these recommendations suggest preferred approaches to the diagnostic, thera- peutic, and preventive aspects of care. They are intended to be ?exible, in contrast to standards of care, which are in?exible policies to be followed in every case. Speci?c

2013 American Association for the Study of Liver Diseases

88. Medical interventions for traumatic hyphema (PubMed)

not affect final visual acuity, but did appear to reduce the risk of secondary bleeding. However, patients taking one of the antifibrinolytics, aminocaproic acid, appeared to have more nausea and vomiting compared with control patients. Two other antifibrinolytics, tranexamic acid and aminomethylbenzoic acid, also reduced the risk of secondary hemorrhage, but there was limited information about adverse events. It was unclear whether these medications reduced the complications of secondary hemorrhage (e.g (...) seems to be as effective as aminocaproic acid in terms of effect on secondary hemorrhage but with fewer gastric side effects. Data from the few studies of the effect of corticosteroids on final VA and risk of secondary hemorrhage in hyphema patients do not support the presumed benefits, though corticosteroid usage may aid in relieving the associated inflammation in such cases. Taking into consideration the risk of side effects for various potential medical treatments (antifibrinolytic agents

Full Text available with Trip Pro

2010 Cochrane Database of Systematic Reviews

89. Medical Work-Up of Uveitis

Medical Work-Up of Uveitis Medical Work-Up of Uveitis – Clinical Correlations Search Medical Work-Up of Uveitis February 16, 2011 6 min read By Mary Whitman, MD Faculty Peer Reviewed Clinical question: What should the medical work-up be for an adult newly diagnosed with uveitis? Uveitis, defined as intraocular inflammation of the eye, can be idiopathic and limited to the eyes, or can be a manifestation of systemic inflammatory diseases and infectious diseases. . However, uveitis (...) . The term “panuveitis” is used when more than one area is involved. Clinical course is defined as acute, chronic, or . These distinctions are important, as different presentations of uveitis are associated with different systemic diseases, and should guide further investigations. The most important first step for all patients with uveitis is a complete, detailed history and full physical exam. In many patients, there will be other signs or symptoms of systemic disease, such as joint pain, diarrhea

2011 Clinical Correlations

90. Effects of Chinese Medicine as Adjunct Medication for Adjuvant Chemotherapy Treatments of Non-Small Cell Lung Cancer Patients (PubMed)

with additional TCM (intervention, n = 156) groups. The primary endpoint was QOL scores; secondary endpoints were the toxicity and safety of the regimens. The NP/NC regimen caused mild (grade 1 or 2) non-hematologic toxic effects in the patients comprising vomiting (43.6%), fatigue (36.9%), pain (23%), dry mouth (27.6%) and diarrhea (7.9%). The incidence of adverse events was significantly lower in the intervention group than in the control group (0.57% vs 4.02%, P = 0.037). Transient severe (grade 3 or 4 (...) Effects of Chinese Medicine as Adjunct Medication for Adjuvant Chemotherapy Treatments of Non-Small Cell Lung Cancer Patients The aim was to evaluate the effects of traditional Chinese medicine (TCM) as a combination medication with adjuvant chemotherapy on postoperative early stage non-small cell lung cancer (NSCLC) patients. The 314 patients with completely resected stage IB, II or IIIA cancers were assigned into vinorelbine plus cisplatin/carboplatin (NP/NC) (control, n = 158) and NP/NC

Full Text available with Trip Pro

2017 Scientific reports Controlled trial quality: uncertain

91. Evaluating an Intervention to Increase Use of Call Centre Support for Self-managed Medical Abortion

doses Self-reported satisfaction with self-administration of MA [ Time Frame: Day 14 after taking the first pill ] Satisfaction with the overall process, would recommend to a friend who needed an abortion, would use the same method again if needed an abortion again, feeling adequately prepared for various aspects of the medical abortion process. Secondary Outcome Measures : Cost of intervention per unit of call centre use [ Time Frame: Day 14 after taking first pill ] Increased unit cost (...) needing IV antibiotics and undiagnosed (at the time of MA administration) ectopic pregnancy needing surgery or other treatment, a continuing pregnancy needing an uterine aspiration, an incomplete abortion needing uterine aspiration or further medication, severe allergic reaction, severe vomiting or diarrhea and admission to a health facility for any of the above. Other Outcome Measures: Proportion of pharmacy workers encouraging mystery clients to use the MSZ call centre number [ Time Frame: Within 4

2017 Clinical Trials

92. Non-inferiority Trials of the Quality of Nurse Consultation Versus a Medical Consultation in Travel Medicine.

to the individual prevention of the traveler's Malaria, diarrhea and sexually transmitted infections. [ Time Frame: At day 1 ] Evaluated by a post-consultation memorization survey Secondary Outcome Measures : Quality score of the support consultation evaluating the memorization of Information by travelers. [ Time Frame: At day 1 ] Evaluated by memorisation survey Level of satisfaction of travelers [ Time Frame: At day 1 ] The level of satisfaction will be assessed by a visual scale. The relevance of the choice (...) Non-inferiority Trials of the Quality of Nurse Consultation Versus a Medical Consultation in Travel Medicine. Non-inferiority Trials of the Quality of Nurse Consultation Versus a Medical Consultation in Travel Medicine. - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies

2017 Clinical Trials

93. Blood Test for Early Detection of Breast Cancer Using Todos Medical -Breast 1(TM-B1) Assay

Blood Test for Early Detection of Breast Cancer Using Todos Medical -Breast 1(TM-B1) Assay Blood Test for Early Detection of Breast Cancer Using Todos Medical -Breast 1(TM-B1) Assay - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more (...) studies before adding more. Blood Test for Early Detection of Breast Cancer Using Todos Medical -Breast 1(TM-B1) Assay (TM-B1) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03343691 Recruitment Status : Recruiting First

2017 Clinical Trials

94. Trial to Evaluate the Efficacy on Glycemic Variability and Safety of Gemigliptin Compared With Dapagliflozin Added on Metformin Alone or Diabetes Medication Naïve Patient in Type 2 Diabetes Mellitus (Stable II Study)

Trial to Evaluate the Efficacy on Glycemic Variability and Safety of Gemigliptin Compared With Dapagliflozin Added on Metformin Alone or Diabetes Medication Naïve Patient in Type 2 Diabetes Mellitus (Stable II Study) Trial to Evaluate the Efficacy on Glycemic Variability and Safety of Gemigliptin Compared With Dapagliflozin Added on Metformin Alone or Diabetes Medication Naïve Patient in Type 2 Diabetes Mellitus (Stable II Study) - Full Text View - ClinicalTrials.gov Hide glossary Glossary (...) Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Trial to Evaluate the Efficacy on Glycemic Variability and Safety of Gemigliptin Compared With Dapagliflozin Added on Metformin Alone or Diabetes Medication Naïve Patient in Type 2 Diabetes Mellitus (Stable II Study

2017 Clinical Trials

95. Causes of variability in prevalence rates of communicable diseases among secondary school Students in Kisumu County, Kenya (PubMed)

in female (7.96%) than male students.This study has revealed that the prevalences of diarrhea, tuberculosis, pneumonia and other respiratory tract infections are lower among female secondary school students than males and that the prevalence of malaria is higher in males than females. Age of secondary school students is a significant vulnerability factor for malaria, diarrhea, tuberculosis and pneumonia, which were the important communicable diseases most prevalent among secondary school students (...) Causes of variability in prevalence rates of communicable diseases among secondary school Students in Kisumu County, Kenya To determine causes of variability in communicable disease prevalence rates among students in secondary schools to inform policy formulation in the public health sector.A representative cluster sample size for students was estimated using Fisher et al.'s formula while schools, sub-counties and education zones were clustered and sample size was calculated based

Full Text available with Trip Pro

2016 Zeitschrift Fur Gesundheitswissenschaften

96. Epidemiology and Recurrence Rates of Clostridium difficile Infections in Germany: A Secondary Data Analysis (PubMed)

Epidemiology and Recurrence Rates of Clostridium difficile Infections in Germany: A Secondary Data Analysis Clostridium difficile infection (CDI) is the most common cause of health-care-associated infectious diarrhea. Recurrence rates are as high as 20-30% after standard treatment with metronidazole or vancomycin, and appear to be reduced for patients treated with fidaxomicin. According to the literature, the risk of CDI recurrence increases after the second relapse to 30-65%. Accurate data (...) for Germany are not yet available.Based on the research database of arvato health analytics (Munich, Germany), a secondary data analysis for the incidence, treatment characteristics and course of CDI was performed. The database included high granular accounting information of about 1.46 million medically insured patients covering the period 2006-2013, being representative for Germany. The analysis was based on new-onset CDI in 2012 in patients which either received outpatient antibiotic therapy for CDI

Full Text available with Trip Pro

2016 Infectious diseases and therapy

97. Syphilis: an atypical case of sepsis and multiple anogenital lesions in secondary syphilis (PubMed)

with severe septic shock and multiple anogenital lesions in an immunocompetent host. A 22-year-old male with no significant past medical history presented with fevers, chills, sore throat, diaphoresis, and diarrhea. He was febrile, tachycardic, hypotensive, and unresponsive to fluid resuscitation requiring short-term vasopressor support. Physical exam revealed diffuse lymphadenopathy; lower extremity macular rash involving the soles of the feet; papular non-pustular lesions on the scrotum; and a 0.5 cm (...) Syphilis: an atypical case of sepsis and multiple anogenital lesions in secondary syphilis The incidence of syphilis has historically been cyclical in nature, often in relation to the rise and fall of public health initiatives directed toward eradication along with social attitudes toward sexual practices. The incidence of syphilis has increased by 15% in the last 6 years in the United States, with similar increases worldwide. Herein, we present an atypical case of syphilis presenting

Full Text available with Trip Pro

2016 Journal of community hospital internal medicine perspectives

98. Pharmacoepidemiological Study of Secondary Hyperparathyroidism in Lorraine

/DOQI Secondary Outcome Measures : Phosphocalcium product level [ Time Frame: 2 years ] Serum calcium level [ Time Frame: 2 years ] Serum phosphorus level [ Time Frame: 2 years ] Symptoms and / or clinical events caused by hyperparathyroidism [ Time Frame: 2 years ] using clinical and paraclinical examinations Tolerance of therapeutic interventions: nausea, vomiting, diarrhea, hypocalcemia [ Time Frame: 2 years ] using clinical and paraclinical examinations The quality of life [ Time Frame: 2 years (...) but dialysed in a unit outside Lorraine. Diagnosis of secondary hyperparathyroidism with higher parathormone or equal to 500 pg / ml placed before 1/4/2009. Patient who have received medical treatment with cinacalcet or by surgical parathyroidectomy for secondary hyperparathyroidism. Patient expressing opposition to the collection of information. Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research

2016 Clinical Trials

99. Fecal Microbiota Transplantation to Treat Recurrent C. Difficile Associated Diarrhea Via Retention Enema or Oral Route

preparation. Intervention - Lyophilized Microbiota will be delivered orally Biological: Lyophilized Microbiota Lyophilized Microbiota will be delivered orally. Outcome Measures Go to Primary Outcome Measures : Safety as Assessed by Number of Participants With Any Adverse Events (AE)s [ Time Frame: 6 months after the procedure ] any untoward medical occurrence associated with the use of PRIM-DJ2727 whether or not considered drug related is considered as an adverse event (AE) Secondary Outcome Measures (...) Fecal Microbiota Transplantation to Treat Recurrent C. Difficile Associated Diarrhea Via Retention Enema or Oral Route Fecal Microbiota Transplantation to Treat Recurrent C. Difficile Associated Diarrhea Via Retention Enema or Oral Route - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum

2014 Clinical Trials

100. A Study to Compare Safety and Efficacy of OPT-80(Fidaxomicin) With Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

Frame: Up to 38 days ] Global cure rate is the rate of the subjects satisfying both of the following: being cured at the completion of study drug administration; without recurrence during the follow-up period Secondary Outcome Measures : Cure rate [ Time Frame: Day 10 -11 of the study period ] Recurrence rate of CDAD [ Time Frame: during the 4-week follow-up period, up to Day 38 ] Time to resolution of diarrhea [ Time Frame: up to 38 days ] Microbiological efficacy [ Time Frame: Up to 38 days (...) A Study to Compare Safety and Efficacy of OPT-80(Fidaxomicin) With Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD) A Study to Compare Safety and Efficacy of OPT-80(Fidaxomicin) With Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save

2014 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>